{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T23:10:07Z","timestamp":1755817807478,"version":"3.44.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,21]]},"DOI":"10.7759\/cureus.90693","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T22:48:35Z","timestamp":1755816515000},"source":"Crossref","is-referenced-by-count":0,"title":["A Single-Center Retrospective Comparative Study of Conventional and Accelerated Fractionated Radiotherapy for Early-Stage Laryngeal Cancer"],"prefix":"10.7759","author":[{"given":"Juno","family":"Kaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensei","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Someya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0194599815577103","article-title":"Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis","volume":"152","author":"Greulich MT","year":"2015","unstructured":"Greulich MT, Parker NP, Lee P, Merati AL, Misono S. Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2015, 152:811-9. 10.1177\/0194599815577103","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.04.007","article-title":"Altered-fractionation radiotherapy improves local control in early-stage glottic carcinoma: a systematic review and meta-analysis of 1762 patients","volume":"93","author":"Sapienza LG","year":"2019","unstructured":"Sapienza LG, Ning MS, Taguchi S, et al.. Altered-fractionation radiotherapy improves local control in early-stage glottic carcinoma: a systematic review and meta-analysis of 1762 patients. Oral Oncol. 2019, 93:8-14. 10.1016\/j.oraloncology.2019.04.007","journal-title":"Oral Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30458-8","article-title":"Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis","volume":"18","author":"Lacas B","year":"2017","unstructured":"Lacas B, Bourhis J, Overgaard J, et al.. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol. 2017, 18:1221-37. 10.1016\/S1470-2045(17)30458-8","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(02)03938-x","article-title":"Results of radiotherapy for T2N0 glottic carcinoma: does the \"2\" stand for twice-daily treatment?","volume":"55","author":"Garden AS","year":"2003","unstructured":"Garden AS, Forster K, Wong PF, et al.. Results of radiotherapy for T2N0 glottic carcinoma: does the \"2\" stand for twice-daily treatment?. Int J Radiat Oncol Biol Phys. 2003, 55:322-8. 10.1016\/s0360-3016(02)03938-x","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.06.014","article-title":"Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time","volume":"64","author":"Yamazaki H","year":"2006","unstructured":"Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2006, 64:77-82. 10.1016\/j.ijrobp.2005.06.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-008-1819-1","article-title":"Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors","volume":"184","author":"Sakata K","year":"2008","unstructured":"Sakata K, Someya M, Hori M, Nakata K, Takagi M, Hareyama M. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors. Strahlenther Onkol. 2008, 184:364-9. 10.1007\/s00066-008-1819-1","journal-title":"Strahlenther Onkol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.09.016","article-title":"A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study","volume":"110","author":"Moon SH","year":"2014","unstructured":"Moon SH, Cho KH, Chung EJ, et al.. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study. Radiother Oncol. 2014, 110:98-103. 10.1016\/j.radonc.2013.09.016","journal-title":"Radiother Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.04.041","article-title":"Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)","volume":"89","author":"Trotti A 3rd","year":"2014","unstructured":"Trotti A 3rd, Zhang Q, Bentzen SM, et al.. Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512). Int J Radiat Oncol Biol Phys. 2014, 89:958-63. 10.1016\/j.ijrobp.2014.04.041","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23641","article-title":"Accelerated radiotherapy for T1 to T2 glottic cancer","volume":"37","author":"Motegi A","year":"2015","unstructured":"Motegi A, Kawashima M, Arahira S, et al.. Accelerated radiotherapy for T1 to T2 glottic cancer. Head Neck. 2015, 37:579-84. 10.1002\/hed.23641","journal-title":"Head Neck"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23967","article-title":"Intensity-modulated radiotherapy for early-stage glottic cancer","volume":"38 Suppl 1","author":"Berwouts D","year":"2016","unstructured":"Berwouts D, Swimberghe M, Duprez F, et al.. Intensity-modulated radiotherapy for early-stage glottic cancer. Head Neck. 2016, 38 Suppl 1:E179-84. 10.1002\/hed.23967","journal-title":"Head Neck"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpor.2016.08.001","article-title":"Hypofractionated accelerated radiotherapy in T1-3 N0 cancer of the larynx: a prospective cohort study with historical controls","volume":"21","author":"Szutkowski Z","year":"2016","unstructured":"Szutkowski Z, Kawecki A, Jarz\u0105bski A, Laskus Z, Krajewski R, Michalski W, Kuko\u0142owicz P. Hypofractionated accelerated radiotherapy in T1-3 N0 cancer of the larynx: a prospective cohort study with historical controls. Rep Pract Oncol Radiother. 2016, 21:537-43. 10.1016\/j.rpor.2016.08.001","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy036","article-title":"Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study (JCOG0701)","volume":"29","author":"Kodaira T","year":"2018","unstructured":"Kodaira T, Kagami Y, Shibata T, et al.. Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study (JCOG0701). Ann Oncol. 2018, 29:992-7. 10.1093\/annonc\/mdy036","journal-title":"Ann Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.06.251","article-title":"Long-term follow-up of a randomized controlled trial on accelerated radiation therapy versus standard fractionated radiation therapy for early glottic cancer (JCOG0701A3)","volume":"117","author":"Kodaira T","year":"2023","unstructured":"Kodaira T, Kagami Y, Machida R, et al.. Long-term follow-up of a randomized controlled trial on accelerated radiation therapy versus standard fractionated radiation therapy for early glottic cancer (JCOG0701A3). Int J Radiat Oncol Biol Phys. 2023, 117:1118-24. 10.1016\/j.ijrobp.2023.06.251","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers HR","year":"1988","unstructured":"Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988, 27:131-46. 10.3109\/02841868809090333","journal-title":"Acta Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.11182\/jastro1989.10.215","article-title":"The impact of biologic effective dose corrected for overall treatment time upon tumor control of stage I and II laryngeal cancers","volume":"10","author":"Mariya Y","year":"1998","unstructured":"Mariya Y, Watanabe S, Katou K, et al.. The impact of biologic effective dose corrected for overall treatment time upon tumor control of stage I and II laryngeal cancers. Jpn Soc Ther Radiol Oncol. 1998, 10:215-22. 10.11182\/jastro1989.10.215","journal-title":"Jpn Soc Ther Radiol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-8140(03)00059-8","article-title":"Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience","volume":"68","author":"Gowda RV","year":"2003","unstructured":"Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience. Radiother Oncol. 2003, 68:105-11. 10.1016\/s0167-8140(03)00059-8","journal-title":"Radiother Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.04.016","article-title":"Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement","volume":"107","author":"Thomson DJ","year":"2020","unstructured":"Thomson DJ, Palma D, Guckenberger M, et al.. Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement. Int J Radiat Oncol Biol Phys. 2020, 107:618-27. 10.1016\/j.ijrobp.2020.04.016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2020.1785290","article-title":"Radiotherapy in the era of COVID-19","volume":"20","author":"Lancia A","year":"2020","unstructured":"Lancia A, Bonzano E, Bottero M, Camici M, Catellani F, Ingrosso G. Radiotherapy in the era of COVID-19. Expert Rev Anticancer Ther. 2020, 20:625-7. 10.1080\/14737140.2020.1785290","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.03.011","article-title":"Adapting radiation therapy treatments for patients with breast cancer during the COVID-19 pandemic: hypo-fractionation and accelerated partial breast irradiation to address World Health Organization recommendations","volume":"5","author":"Al-Rashdan A","year":"2020","unstructured":"Al-Rashdan A, Roumeliotis M, Quirk S, et al.. Adapting radiation therapy treatments for patients with breast cancer during the COVID-19 pandemic: hypo-fractionation and accelerated partial breast irradiation to address World Health Organization recommendations. Adv Radiat Oncol. 2020, 5:575-6. 10.1016\/j.adro.2020.03.011","journal-title":"Adv Radiat Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6661","article-title":"The impact of the COVID-19 pandemic on radiotherapy delivery in Japan: an observational study based on the national database","volume":"12","author":"Tamari K","year":"2023","unstructured":"Tamari K, Kishigami M, Nagata Y, et al.. The impact of the COVID-19 pandemic on radiotherapy delivery in Japan: an observational study based on the national database. Cancer Med. 2023, 12:21032-40. 10.1002\/cam4.6661","journal-title":"Cancer Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2016.34.1.18","article-title":"Volumetric modulated arc therapy for carotid sparing in the management of early glottic cancer","volume":"34","author":"Kim YS","year":"2016","unstructured":"Kim YS, Lee J, Park JI, Sung W, Lee SM, Kim GE. Volumetric modulated arc therapy for carotid sparing in the management of early glottic cancer. Radiat Oncol J. 2016, 34:18-25. 10.3857\/roj.2016.34.1.18","journal-title":"Radiat Oncol J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2019.00619","article-title":"Intensity-modulated radiation therapy in early stage squamous cell carcinoma of the larynx: treatment trends and outcomes","volume":"38","author":"Wegner RE","year":"2020","unstructured":"Wegner RE, Abel S, Bergin JJ, Colonias A. Intensity-modulated radiation therapy in early stage squamous cell carcinoma of the larynx: treatment trends and outcomes. Radiat Oncol J. 2020, 38:11-7. 10.3857\/roj.2019.00619","journal-title":"Radiat Oncol J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-079089","article-title":"Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis","volume":"386","author":"Lee SF","year":"2024","unstructured":"Lee SF, Kennedy SK, Caini S, et al.. Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis. BMJ. 2024, 386:e079089. 10.1136\/bmj-2023-079089","journal-title":"BMJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/398312-a-single-center-retrospective-comparative-study-of-conventional-and-accelerated-fractionated-radiotherapy-for-early-stage-laryngeal-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T22:48:37Z","timestamp":1755816517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/398312-a-single-center-retrospective-comparative-study-of-conventional-and-accelerated-fractionated-radiotherapy-for-early-stage-laryngeal-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.90693","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,21]]}}}